CNTA — Centessa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Centessa Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	16.6	7.23	595	394	257
Net Total Receivables	1.5	2.93	16.8	26.7	39.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19.2	11.2	629	438	315
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.162	1.17	13
Long Term Notes Receivable
Other Long Term Assets
Total Assets	19.7	11.7	630	444	360
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.93	8.62	24.6	38.3	39.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.07	8.62	138	108	124
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	13.7	3.1	492	336	236
Total Liabilities & Shareholders' Equity	19.7	11.7	630	444	360
Total Common Shares Outstanding